Eden Research plc Exercise of Options (2991N)
May 08 2018 - 1:00AM
UK Regulatory
TIDMEDEN
RNS Number : 2991N
Eden Research plc
08 May 2018
8 May 2018
Eden Research plc
("Eden" or "Company")
Exercise of Options
Director/PDMR Shareholding
Eden Research plc (AIM: EDEN), the AIM listed company that
provides breakthrough natural microencapsulation technologies to
the global agrochemicals, animal health and consumer products
industries, announces it has issued 125,000 ordinary shares of 1
pence each in the Company ("Ordinary Shares") following the
exercise of 125,000 options at 10.4 pence per share by the
Company's Chief Financial Officer, Alex Abrey, under the Company's
share option scheme.
Application has been made for the new Ordinary Shares to be
admitted to trading on AIM, which is expected to take place on 14
May 2018. The new Ordinary Shares will rank, pari passu, with the
existing Ordinary Shares in issue.
Following the transaction outlined above Mr Abrey's interest in
the share capital of the Company has increased to a total of
1,163,160 Ordinary Shares representing 0.56 per cent. of the
Company's issued share capital enlarged pursuant to the exercise of
options.
Total Voting Rights
Following the issue of the new Ordinary Shares, the Company will
have 207,189,337 ordinary shares of 1 pence each in issue. No
Ordinary Shares are held in treasury. The figure of 207,189,337 may
be used by the Company's shareholders as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency
Rules.
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provide further details of the
PDMR dealings set out above.
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Mr Alex Abrey
------------------------------------------------------- ------------------------------------------------------
2 Reason for the notification
---------------------------------------------------------------------------------------------------------------
a) Position/status Chief Financial Officer
------------------------------------------------------- ------------------------------------------------------
b) Initial notification /Amendment Initial notification
------------------------------------------------------- ------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---------------------------------------------------------------------------------------------------------------
a) Name Eden Research plc
------------------------------------------------------- ------------------------------------------------------
b) LEI 213800ZWTYTVQQSM3J85
------------------------------------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of Ordinary shares of 1 pence each in the Company
instrument ("Ordinary Shares")
Identification code GB0001646941
------------------------------------------------------- ------------------------------------------------------
b) Nature of the transaction Exercise of Options over Ordinary Shares
------------------------------------------------------- ------------------------------------------------------
Exercise Price(s) Volume(s)
c) Price(s) and volume(s) 10.4 pence per 125,000 Ordinary
share Shares
------------------
------------------------------------------------------- ------------------------------------------------------
d) Aggregated information
- Aggregated volume
N/A (single transaction)
- Price
------------------------------------------------------- ------------------------------------------------------
e) Date of the transaction 07/05/2018
------------------------------------------------------- ------------------------------------------------------
f) Place of the transaction Outside of a trading venue.
------------------------------------------------------- ------------------------------------------------------
For further information contact:
Eden Research plc www.edenresearch.com
Sean Smith
Alex Abrey 01285 359 555
Shore Capital (Nomad) 020 7408 4090
Stephane Auton / Patrick Castle
Powerscourt (Financial PR) 020 7250 1446
Nick Dibden
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCGUGDUCDGBGII
(END) Dow Jones Newswires
May 08, 2018 02:00 ET (06:00 GMT)
Eden Research (LSE:EDEN)
Historical Stock Chart
From Apr 2024 to May 2024
Eden Research (LSE:EDEN)
Historical Stock Chart
From May 2023 to May 2024